Table 1.
Characteristics of included patients
| Tetracyclines, n = 180 | Clindamycin and rifampicin, n = 103 | p value | |
|---|---|---|---|
| Patient characteristics | |||
| Gender | |||
| Females, n (%) | 106 (58.9) | 56 (54.4) | 0.533 |
| Age, median [IQR] | 37 [26–46] | 36 [27–45] | 0.917 |
| Missing, n | 0 | 1 | |
| Age of onset, median [IQR] | 21 [15–30] | 21 [16–28] | 0.854 |
| Missing, n | 3 | 0 | |
| Disease duration, median [IQR] | 10 [6–19] | 10 [5–17] | 0.415 |
| Missing, n | 3 | 1 | |
| BMI, mean (SD) | 29.81 (6.1) | 29.21 (6.2) | 0.428 |
| Missing, n | 6 | 0 | |
| Current smoker, n (%) | 110 (61.8) | 56 (56.6) | 0.443 |
| Missing, n | 2 | 4 | |
| Family history of HS, n (%) | 58 (34.3) | 34 (35.1) | 1.000 |
| Missing, n | 11 | 6 | |
| PROMs | |||
| DLQI, mean (SD) | 13.3 (7.5) | 15.1 (7.9) | 0.071 |
| Missing, n | 8 | 7 | |
| NRS Pain, median [IQR] | 6 [4–8] | 7 [5–8] | 0.005 |
| Missing, n | 7 | 3 | |
| NRS Pruritus, median [IQR] | 3 [0–6] | 4 [0–7] | 0.204 |
| Missing, n | 13 | 8 | |
| Physician scores | |||
| Inflammatory nodules, median [IQR] | 3.5 [1.0–6.0] | 4 [2–9] | 0.029 |
| Abscesses, median [IQR] | 0.0 [0.0–2.0] | 0 [0–2] | 0.975 |
| Draining sinus tracts, median [IQR] | |||
| Hurley stage | 1.0 [0.0–2.0] | 1 [0–4] | 0.003 |
| Stage I, n (%) | 54 (30.2) | 14 (13.6) | 0.004 |
| Stage II, n (%) | 90 (50.3) | 58 (56.3) | |
| Stage III, n (%) | 35 (19.5) | 31 (30.1) | |
| Missing, n | 1 | 0 | |
| IHS4, median [IQR] | 9.0 [5.0–18.5] | 13.0 [6.0–27.0] | 0.019 |
| Mild, n (%) | 29 (16.1) | 8 (7.8) | 0.032 |
| Moderate, n (%) | 77 (42.8) | 38 (36.9) | |
| Severe, n (%) | 74 (41.1) | 57 (55.3) |